{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T23:10:09Z","timestamp":1743894609885,"version":"3.40.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1676,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002077","name":"Epidermolysis Bullosa Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DR1-01454"],"award-info":[{"award-number":["DR1-01454"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/jid.2011.38","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T06:51:47Z","timestamp":1302763907000},"page":"996-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful Investigational New Drug Preparation without Reinventing the Wheel"],"prefix":"10.1016","volume":"131","author":[{"given":"Emily S.","family":"Gorell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Tichy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred T.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.38_bb0010","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1377\/hlthaff.25.2.420","article-title":"Estimating The cost of new drug development: is it really $802 million?","volume":"25","author":"Adams","year":"2006","journal-title":"Health Aff"},{"key":"10.1038\/jid.2011.38_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nbt0709-606","article-title":"Developing safe therapies from human pluripotent stem cells","volume":"27","author":"Carpenter","year":"2009","journal-title":"Nat Biotech"},{"key":"10.1038\/jid.2011.38_bb0020","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1173712","article-title":"FDA regulation of stem cell-based products","volume":"324","author":"Fink","year":"2009","journal-title":"Science"},{"year":"1995","series-title":"Food and Drug Administration. Guidance for industry: content and format of Investigational New Drug Applications (INDs) for Phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products","author":"FDA","key":"10.1038\/jid.2011.38_bb0025"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0030"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0035"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0040"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0045"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0050"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0055"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0060"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0065"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0070"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0075"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0080"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0085"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0090"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0095"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0100"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0105"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0110"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0115"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0120"},{"author":"FDA","key":"10.1038\/jid.2011.38_bb0125"},{"author":"National Institutes of Health, Office of Human Subjects Research","key":"10.1038\/jid.2011.38_bb0130"},{"author":"National Institutes of Health, Office of Human Subjects Research","key":"10.1038\/jid.2011.38_bb0135"},{"author":"Department of Agriculture","key":"10.1038\/jid.2011.38_bb0145"},{"key":"10.1038\/jid.2011.38_bb0140","unstructured":"Stanford University, Office of the Dean of Research. Stanford University Human Research Protection Program (HRPP). http:\/\/humansubjects.stanford.edu\/hrpp\/Chapter1.html"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15352659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15352659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:49:11Z","timestamp":1743893351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15352659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0022202X15352659"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.38","relation":{},"ISSN":["0022-202X"],"issn-type":[{"type":"print","value":"0022-202X"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Investigational New Drug Preparation without Reinventing the Wheel","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.38","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}